The FDA says Integra Lifesciences has inadequately responded to violations that it found at the company’s TEI Biosciences plant in Boston. Integra Lifesciences’ Boston facility makes extracellular bovine matrix products for tissue repair and regeneration, wound care and more. In May, the company voluntarily recalled all tissue-related products made in Boston and distributed between March 1, […]
Integra LifeSciences
Integra Lifesciences expects to resume manufacturing in Boston
Integra LifeSciences (NASDAQ: IART) recently announced that it plans to resume manufacturing in its Boston facility by the end of the fourth quarter. Just two months before, Integra voluntarily recalled all tissue-related products made in Boston and distributed between March 1, 2018 and May 22, 2023. The recalled products included SurgiMend, PriMatrix, Revize and TissueMend. […]
Integra Lifesciences completes enrollment in DuraSorb monofilament mesh IDE study
Integra LifeSciences announced that it completed enrollment ints U.S. DuraSorb trial. The FDA investigational device exemption (IDE) clinical study evaluates DuraSorb in two-stage breast reconstruction. The bioabsorbable matrix-based monofilament mesh currently has FDA clearance to reinforce soft tissue where weakness exists. Princeton, New Jersey-based Integra said its study marks the first and only active, multi-center […]
Integra Lifesciences names Lea Daniels Knight as CFO
Integra LifeSciences this week announced it appointed Lea Daniels Knight as executive Vice President and chief financial officer, effective June 28. Knight has more than 30 years of experience in global companies with significant operating scale and complexity. She most recently was executive VP of business finance for Booz Allen Hamilton, where she was responsible […]
Integra LifeSciences stock takes a hit despite Street-beating Q1
Integra LifeSciences shares dipped today despite first-quarter results that beat the consensus revenue forecast. Shares of IART slid 8.5% to $53.84 apiece as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 1.4%. BTIG analyst Ryan Zimmerman said an implied set-up for the […]
Integra stock dips despite Street-beating Q4
Integra LifeSciences (Nasdaq:IART) shares fell slightly today despite fourth-quarter results that topped the consensus forecast. Shares of IART dipped 1.25% to $56 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 8.7%. The Princeton, New Jersey-based surgical and medical instrument maker posted […]
Integra Lifesciences’ CFO is leaving for the soup business
Integra Lifesciences CFO Carrie Anderson is leaving to take a job at another New Jersey–based company, but it’s not a medtech business. Campbell Soup Co. announced today that Anderson will become its EVP and CFO, effective Feb. 6. She succeeds Mick Beekhuizen, who became president of the Camden, New Jersey–based company’s Meals & Beverages division […]
Integra LifeSciences completes Surgical Innovation Associates acquisition
Integra LifeSciences (Nasdaq:IART) announced today that it completed its acquisition of Surgical Innovation Associates (SIA). Princeton, New Jersey-based Integra announced that it agreed to acquire SIA last week. SIA develops, markets and sells the DuraSorb resorbable synthetic matrix for plastic and reconstruction surgery. Integra believes the acquisition advances its global strategy in breast reconstruction. The deal expands […]
Integra LifeSciences to acquire Surgical Innovation Associates
Integra LifeSciences (Nasdaq:IART) announced today that it entered into a definitive agreement to acquire Surgical Innovation Associates (SIA). SIA develops, markets and sells the DuraSorb resorbable synthetic matrix for plastic and reconstruction surgery. Princeton, New Jersey–based Integra said in a news release that the acquisition advances its global strategy in breast reconstruction. The deal expands […]
Integra Lifesciences rises on Street-beating Q3 results
Integra Lifesciences (NSDQ:IART) today posted third-quarter results that beat the overall consensus on Wall Street. The surgical and medical instrument maker reported profits of $49.9 million, or 60¢ per share, on sales of $385.2 million for the three months ended Sept. 30, 2022. The Q3 results represent a bottom-line gain of 15.5% on a sales loss […]
Integra’s CereLink ICP Monitor recall is Class I
The FDA has labeled the recall of the Integra LifeSciences (Nasdaq:IART) CereLink system as Class I, the most serious kind. Integra designed its CereLink system for intracranial pressure (ICP) monitoring. Last week, the company announced an immediate, voluntary global product removal of the systems. An FDA notice classified the U.S. recall, initiated by Integra on […]
